CAR T cell therapy for fighting IPF: perspectives on a living drug
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
CAR T cell therapy is being considered as a potential treatment for idiopathic pulmonary fibrosis (IPF). Perspectives on the use of this "living drug" are being explored. The therapy's application in fighting IPF is being examined from various viewpoints.